Wikipedia -WSS

Wikipedia

author：fashion 2025-09-27 22:49:19 - browse：11492

research funding, medical devices — APStock

WASHINGTON — A federal district judge on Monday granted the Biden administration’s request to dismiss a lawsuit challenging Medicare’s new drug price negotiation program from the drug industry lobbying organization PhRMA.

The move is an early but positive sign for the Biden administration in a legal fight that could stretch for years, as a host of major drugmakers, including Merck, Bristol Myers Squibb, and Johnson & Johnson, have also filed lawsuits over the constitutionality of Medicare’s new powers. The first round of drug negotiations is ongoing, and a judge heard oral arguments in a challenge brought by AstraZeneca just last month.

Newsletters

Sign up for D.C. Diagnosis

Washington never stops. Cut through the noise with our essential updates on health care politics and policy

Please enter a valid email address. Privacy Policy

The National Infusion Center Association and the Global Colon Cancer Association are also plaintiffs in PhRMA’s lawsuit. The judge dismissed the National Infusion Center Association from the case because it did not have subject matter jurisdiction to bring the lawsuit. And because NICA was the only party to the lawsuit that resides in Texas, the judge tossed out the case in its entirety.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Feng Zhang, Grail founder join forces on new gene editing startup

WSS

JPM: CVS says Medicare Advantage patients are impacting profits

Chronically ill young patients struggle to find fertility info

Study: Black kids more likely to die after surgery than white kids

Federal weight loss drug coverage is 30 years out of date

Gut bacteria may contribute to kidney autoimmunity, study finds

At JPM, Bristol Myers Squibb CEO tries to soothe investor nerves

focus

Wikipedia

Sign up for D.C. Diagnosis

knowledge

Hollywood unions extend contract negotiations for actors

Republican states more likely to report Covid vaccine side effects

Walensky prepares to leave CDC — and Congress — behind

Antibiotic resistance and the global rise in human conflict

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Burning questions for the 2024 JPM Healthcare Conference

In age of alternative facts, a scholarly course on calling out crap

UnitedHealth, in a surprise, takes aim at Steward’s physician group

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Young boy dies in trial for Pfizer Duchenne gene therapy

explore

Insitro, AI biotech unicorn, brings cash, new research to JPM 2024

A single drug, study failures leave Anavex with nothing but cash

AdventHealth escalates lawsuit against insurance vendor Multiplan

Susan Tousi leaves Illumina to head cancer liquid biopsy startup

Four alarming medical procedures we’re glad history forgot

3 medical device trends to watch in 2024

hotspot

focus

entertainment

hotspot